Article
SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
Annals of surgical oncology - 1 Jun 2012
Chen Hsieh-Cheng, Jeng Yung-Ming, Yuan Ray-Hwang, Hsu Hey-Chi, Chen Yu-Ling
Abstract excerpt
BACKGROUND: SIRT1 is a NAD+-dependent deacetylase that plays crucial roles in many biological processes, including stress response, apoptosis, cellular metabolism, adaptation to calorie restriction, aging, and tumorigenesis. The purpose of this study is to elucidate the clinicopathological and functional significance of SIRT1 expression in hepatocellular carcinoma (HCC). METHODS: SIRT1 expression in HCC was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
